← Back to Search

Active MIDCAB for Foot Surgery (MIDCAB Trial)

Phase 4
Waitlist Available
Led By Enrique Goytizolo, MD
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pacu, pod1 (1 day), pod2 (2 days) & pod7 (1 week)
Awards & highlights

MIDCAB Trial Summary

This trial is testing a new way to numb the area around the ankle and foot during surgery, which may provide better pain relief and allow patients to move their foot during surgery and recovery.

Eligible Conditions
  • Foot Surgery
  • Ankle Surgery

MIDCAB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured in the pacu (post-anesthesia care unit) immediately upon patients arrival into the pacu.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured in the pacu (post-anesthesia care unit) immediately upon patients arrival into the pacu. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Block Duration
Secondary outcome measures
Motor Function of Foot and Ankle Post-Operatively
Nausea & Vomiting
Opioid Use
+2 more

MIDCAB Trial Design

1Treatment groups
Experimental Treatment
Group I: Active MIDCABExperimental Treatment1 Intervention
USG with a 25G needle, Bupivacaine 0.5% 30ml with 4mg preservative free dexamethasone divided as follows into the following 5 nerves: Posterior Tibial nerve (10ml), Saphenous nerve (5ml), Deep peroneal Nerve (5ml), Superficial peroneal nerve (5 ml), and Sural Nerve (5ml).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MIDCAB
2022
Completed Phase 4
~20

Find a Location

Who is running the clinical trial?

Hospital for Special Surgery, New YorkLead Sponsor
243 Previous Clinical Trials
59,344 Total Patients Enrolled
1 Trials studying Foot Surgery
1,500 Patients Enrolled for Foot Surgery
Enrique Goytizolo, MDPrincipal InvestigatorHospital for Special Surgery, New York

Media Library

MIDCAB Clinical Trial Eligibility Overview. Trial Name: NCT05368012 — Phase 4
Foot Surgery Research Study Groups: Active MIDCAB
Foot Surgery Clinical Trial 2023: MIDCAB Highlights & Side Effects. Trial Name: NCT05368012 — Phase 4
MIDCAB 2023 Treatment Timeline for Medical Study. Trial Name: NCT05368012 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criteria for this trial encompass individuals below 35 years of age?

"This clinical trial is recruiting individuals aged between 18 and 80."

Answered by AI

Are there any criteria that participants must fulfill to partake in this trial?

"This human trial demands that 20 volunteers aged 18-80 meet the prerequisites of using regional anesthesia, following protocol instructions and having foot or angle surgery."

Answered by AI

Are there currently openings for this clinical testing?

"Affirmative. Clinicaltrials.gov confirms that this investigation, which was originally announced on July 21st 2022 is presently recruiting for 20 volunteers from one setting."

Answered by AI

What potential risks may patients incur from this treatment regimen?

"This treatment has been granted approval, so its safety rating is 3 on the Power team's scale. As a Phase 4 trial, this medicinal intervention can be safely administered to patients."

Answered by AI

How many individuals are being recruited for this experiment?

"Indeed, the clinicaltrials.gov portal states that this study is actively recruiting participants. This medical research was initially posted on July 21st 2022 and most recently modified on October 27th 2022; it seeks to recruit 20 individuals from a single site."

Answered by AI
~7 spots leftby Apr 2025